Background Little information is available about the effect of pneumococcal conjugate
vaccines (PCVs) in low-income countries. We measured the effect of these vaccines on …

Summary Background Pneumococcal conjugate vaccines (PCVs) are used in many low-
income countries but their impact on the incidence of pneumonia is unclear. The Gambia …

Molecular analyses of lung aspirates from Gambian children with severe pneumonia
detected pathogens more frequently than did culture and showed a predominance of …

Discovery and Validation of Biomarkers to Guide Clinical Management of Pneumonia in
African Children | Clinical Infectious Diseases | Oxford Academic Skip to Main Content …

Summary Background The Gambia introduced seven-valent pneumococcal conjugate
vaccine (PCV7) in August 2009, followed by PCV13 in May, 2011, using a schedule of three …

Introduction Authorship parasitism (ie, no authors affiliated with the country in which the
study took place) occurs frequently in research conducted in low-income and middle-income …

Smoke from biomass fuels is a risk factor for pneumonia, the leading cause of child death
worldwide. Although particulate matter (PM) is the metric of choice for studying the health …

SETTING: Greater Banjul and Upper River Regions, The Gambia. OBJECTIVE: To
investigate tractable social, environmental and nutritional risk factors for childhood …

Pleural TB is notoriously difficult to diagnose due to its paucibacillary nature yet it is the most
common cause of pleural effusions in TB endemic countries such as The Gambia. We …

Abstract Background. The Gambia was the first country in Africa to introduce conjugate
Haemophilus influenzae type b (Hib) vaccine, which, as in other developing countries but …